Verition Fund Management LLC Horizon Therapeutics Public LTD CO Transaction History

Verition Fund Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $740,073 - $865,387	7,477 Added 2.08%	367,671 $42.5 Million
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $50.6 Million - $59 Million	-525,002 Reduced 59.31%	360,194 $37 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $51.4 Million - $54.4 Million	479,372 Added 118.12%	885,196 $96.6 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $19.4 Million - $35.3 Million	310,321 Added 324.93%	405,824 $46.2 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $5.06 Million - $7.27 Million	85,920 Added 896.59%	95,503 $5.91 Million

Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $268,451 - $393,413	-3,381 Reduced 26.08%	9,583 $764,000
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $3,197 - $4,062	37 Added 0.29%	12,964 $1.36 Million
Q4 2021 May 03, 2022	SELL	$98.56 - $119.91 $640,640 - $779,415	-6,500 Reduced 33.46%	12,927 $1.39 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $1.91 Million - $2.33 Million	19,427 New	19,427 $2.09 Million
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $350,477 - $441,444	-5,231 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $288,908 - $418,113	5,231 New	5,231 $406,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.